J
Javier P. Gisbert
Researcher at Autonomous University of Madrid
Publications - 1076
Citations - 39753
Javier P. Gisbert is an academic researcher from Autonomous University of Madrid. The author has contributed to research in topics: Helicobacter pylori & Inflammatory bowel disease. The author has an hindex of 95, co-authored 990 publications receiving 33726 citations. Previous affiliations of Javier P. Gisbert include Services Hospital & University of Alcalá.
Papers
More filters
Journal ArticleDOI
[Pan-European Registry on Helicobacter pylori management. Results from Ferencváros, Budapest, 2013-2019].
TL;DR: The first-line concomitant regimen was superior to triple and not significantly better than the sequential or bismuth-based treatment, while second- and third-line regimens achieved largely suboptimal results.
Journal ArticleDOI
Rescue therapies for steroid-refractory acute severe ulcerative colitis: A review.
TL;DR: In this paper , the authors performed a bibliographic search to identify studies focusing on the treatment of steroid-refractory acute severe ulcerative colitis (ASUC) patients.
Journal ArticleDOI
Mo1712 How Frequent are Conversions of Tuberculosis (TBC) Screening Tests Among Inflammatory Bowel Disease (IBD) Patients Under Anti-TNF Treatment?
Fernando Bermejo,Alicia Algaba,María Chaparro,Carlos Taxonera,Antonio López-Sanromán,Iván Guerra,Javier P. Gisbert,David Olivares,Elena Garrido,Gema de la Poza,M. Isabel García-Arata +10 more
Journal Article
[Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
TL;DR: Helicobacter pylori infection and non-steroidal anti-inflammatory drugs (NSAIDs) are the two most important causal factors in gastroduodenal ulcer disease and demonstration of a possible relationship, and the consequent attitude (giving or not eradication therapy) would have important implications.
Journal ArticleDOI
Embolización arterial en el tratamiento de la hemorragia digestiva baja masiva en los pacientes con enfermedad de Crohn
TL;DR: 2 casos clínicos de pacientes que empezaron con un cuadro diarreico y HDB masiva, siendo tratados mediante embolización supraselectiva of the arteria responsable, con buen control del sangrado.